Accueil>>Signaling Pathways>> Proteases>> E1/E2/E3 Enzyme>>BI8622

BI8622

Catalog No.GC65305

BI8622 est un inhibiteur spécifique de l'ubiquitine ligase HUWE1 avec une IC50 de 3,1 μM.

Products are for research use only. Not for human use. We do not sell to patients.

BI8622 Chemical Structure

Cas No.: 1875036-74-0

Taille Prix Stock Qté
10mM (in 1mL DMSO)
346,50 $US
En stock
5mg
315,00 $US
En stock
10mg
495,00 $US
En stock
50mg
1 485,00 $US
En stock
100mg
2 025,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

BI8622 is a specific inhibitor of the ubiquitin ligase HUWE1 with an IC50 of 3.1 μM[1].

BI8622 induces HUWE1 ectopically expresses to abolish ubiquitination of MCL1 with an IC50 value of 6.8 μM in HeLa cells[1].BI8622 suppresses colony formation of Ls174T cells with estimated IC50 value of 8.4 μM[1].BI8622 (10 μM; 1-4 days) treatment retards passage of Ls174T cells through all phases of the cell cycle, with the effect being strongest for G1[1].BI8622 (0-50 μM; 16 hours) retards the degradation of MCL1 in response to UV irradiation by inhibiting HUWE1 in HeLa cells[1].BI8622 inhibits MYC-dependent transactivation in colorectal cancer cells[1].

[1]. Peter S, et al. Tumor cell-specific inhibition of MYC function using small molecule inhibitors of the HUWE1 ubiquitin ligase. EMBO Mol Med. 2014 Dec;6(12):1525-41.

Avis

Review for BI8622

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for BI8622

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.